Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB (BREACH-TB)
Latest Information Update: 10 Mar 2025
At a glance
- Drugs Bedaquiline (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms BREACH-TB
Most Recent Events
- 05 Mar 2025 Planned End Date changed from 1 Nov 2027 to 1 Nov 2030.
- 05 Mar 2025 Planned primary completion date changed from 1 Nov 2027 to 1 Nov 2029.
- 05 Mar 2025 Planned initiation date changed from 1 Mar 2025 to 1 Dec 2025.